Condition
Lesion Skin
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
150%
3 of 2 completed with results
Key Signals
3 with results50% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
Early P 1 (1)
P 2 (1)
Trial Status
Terminated2
Completed2
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07717346Early Phase 1Recruiting
A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease
NCT05742347Not ApplicableTerminated
Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions
NCT03714828Phase 2Completed
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
NCT04249115Not ApplicableTerminatedPrimary
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study
NCT03846531Not ApplicableCompletedPrimary
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Showing all 5 trials